RS
Insider
Randal W. Scott
DirectorRandal W. Scott (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $755K of BBIO (10,000 sh across 3 lots, as filed), executed Feb 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
May 15
Filed May 19
Median ADV $293.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
BBIORecent filings
BBIOSALE
BridgeBio Pharma, Inc.
View filing →
$658K9,800 sh across 3 lots
Exec May 15
Filed May 19 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $755K
10,000 sh across 3 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $666K
10,000 sh across 2 lots
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET